Sign in

    Jacob Bout

    Managing Director and Senior Equity Analyst at CIBC

    Jacob Bout is a Managing Director and Senior Equity Analyst at CIBC World Markets, specializing in equity research within the industrials, chemicals, and agriculture sectors. He provides coverage for major companies including Methanex, Mosaic, and AG Growth International, and has issued high-profile ratings influencing market sentiment; his analyst performance includes a publicly recorded success rate of around 30% on platforms tracking analyst accuracy. Bout began his analyst career before 2013 and has been with CIBC for over a decade, steadily rising to his current Managing Director position. He holds relevant professional credentials for senior research analysts operating at a major Canadian investment bank, including regulatory registrations aligned with CIBC World Markets’ compliance standards.

    Jacob Bout's questions to STANTEC (STN) leadership

    Jacob Bout's questions to STANTEC (STN) leadership • Q2 2024

    Question

    Jacob Bout from CIBC asked about the muted margin impact from recent acquisitions, the expected duration of the integration period, the margin profile of the acquired firms, and the current pricing environment for Stantec's services.

    Answer

    CFO Theresa B. Jang explained that integrating three separate firms concurrently is complex and will mute margin enhancements until the work normalizes through H2 2024 and into H1 2025. She noted the acquired firms have margin profiles similar to Stantec's. CEO Gordon Johnston added that the pricing environment remains favorable, with clients prioritizing project delivery timelines over cost, providing pricing tailwinds.

    Ask Fintool Equity Research AI

    Jacob Bout's questions to Nutrien (NTR) leadership

    Jacob Bout's questions to Nutrien (NTR) leadership • Q2 2024

    Question

    Jacob Bout requested details on the unauthorized derivative contract in Brazil, asking about the circumstances, whether the issue was isolated, and Nutrien's general approach to using derivatives.

    Answer

    CEO Kenneth Seitz confirmed the action was outside normal policy, stemming from organizational changes in Brazil that weakened controls, but was quickly identified and remediated. He assured it was a Brazil-only issue. CFO Pedro Farah added that Nutrien typically uses standard forwards and options for hedging, and the issue was due to actions outside of policy, with new controls now in place.

    Ask Fintool Equity Research AI